Serotonin (5-HT) in veins: Not all in vain

被引:28
|
作者
Linder, A. Elizabeth [1 ]
Ni, Wei [1 ]
Diaz, Jessica L. [1 ]
Szasz, Theodora [1 ]
Burnett, Robert [1 ]
Watts, Stephanie W. [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
关键词
D O I
10.1124/jpet.107.122630
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The circulatory system consists of veins and arteries. Compared with arteries, veins have been neglected in cardiovascular research. Although veins are significantly less muscular than similarly sized arteries, the contribution of veins to cardiovascular homeostasis cannot be left un-noted because veins accommodate 70% of the circulating blood. Circulating blood platelets contain the majority of systemic 5- HT ( 5- hydroxytryptamine; serotonin). Similar to venous function, the physiological role of 5- HT in the cardiovascular system is not well understood. Here, we present not only a review on 5- HT and veins but ways in which these two topics might intersect in a physiologically relevant manner. Here we show the novel findings that veins exhibit higher amounts of intracellular 5- HT than arteries. Moreover, we also show evidence that, similar to arteries, veins have the ability to uptake 5- HT. In this review, we introduce the venous system as a reservoir for 5- HT in the periphery, suggesting that veins, in addition to arteries, may represent an important target for drugs that interfere with the serotonergic system. In addition, the serotonergic system from synthesis to metabolism, 5- HT receptor activation and venous diseases will also be discussed.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 50 条
  • [31] SEROTONIN (5-HT) AND CISPLATIN (CIS) GASTROINTESTINAL TOXICITY
    ARRIGONI, C
    WONG, LCK
    IMONDI, AR
    FASEB JOURNAL, 1988, 2 (04): : A617 - A617
  • [32] Binding of zotepine to serotonin (5-HT) receptor subtypes
    Needham, PL
    Atkinson, J
    Cheetham, SC
    Dinnis, D
    Slater, NA
    OBrien, E
    Heal, DJ
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VIA9 - VIA9
  • [33] Renal interstitial serotonin (5-HT) and dopamine (DA)
    Berndt, TJ
    Liang, M
    Tyce, GM
    Knox, FG
    HYPERTENSION, 1999, 33 (05) : 1261 - 1261
  • [34] MOLECULAR-BIOLOGY OF SEROTONIN (5-HT) RECEPTORS
    PEROUTKA, SJ
    SYNAPSE, 1994, 18 (03) : 241 - 260
  • [35] Importance of serotonin (5-HT) and noradrenaline (NA) in anxiety
    Blier, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S586 - S586
  • [36] Serotonin (5-HT) receptors: pharmacology, function and structure
    Hoyer, Daniel
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 43 - 44
  • [37] LSD, 5-HT (serotonin), and the evolution of a behavioral assay
    Appel, JB
    West, WB
    Buggy, J
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2004, 27 (08): : 693 - 701
  • [38] SEROTONIN (5-HT) RECEPTOR, 5-HT TRANSPORTER AND G-PROTEIN-EFFECTOR EXPRESSION - IMPLICATIONS FOR DEPRESSION
    LESCH, KP
    AULAKH, CS
    WOLOZIN, BL
    MURPHY, DL
    PHARMACOLOGY & TOXICOLOGY, 1992, 71 : 49 - 60
  • [39] Regulation by serotonin (5-HT)-1A receptors of 5-HT and dopamine release in mouse prefrontal cortex
    Matsuda, T
    Ago, Y
    Baba, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S295 - S295
  • [40] Serotonin (5-HT) release in the dorsal raphe and ventral hippocampus: Raphe control of somatodendritic and 5-HT release
    Matos, FF
    Urban, C
    Yocca, FD
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (1-2) : 173 - 190